Nasdaq · CIK 0001093557 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
DEXCOM, INC.
DXCM chart by TradingView
PRICE HISTORY
LIVE · NASDAQDXCM chart by TradingView
- REVENUE FY2025 ENDED DEC 2025
- $4.7B
- EBITDA
- $1.2B
- FREE CASH FLOW
- $1.1B
- EPS
- $2.06
- GROSS MARGIN
- 60.10%
- ROIC
- —
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
26.3x
-92%26.3x313.2x
⤢
P / SALES (TTM)
5.3x
-50%5.1x25.4x
⤢
P / BOOK
10.0x
-47%8.4x30.8x
⤢
EV / EBITDA (TTM)
—
⤢
EV / REVENUE (TTM)
—
⤢
FCF YIELD (TTM)
5.35%
+5.6pp-0.26%5.78%
⤢
DIVIDEND YIELD (TTM)
—
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$1.3B
+780%⤢
EBITDA (DERIVED)
$0.4B
+$0.4B⤢
NET INCOME
$0.2B
+$0.3B⤢
EPS (DILUTED)
$0.64
+7963%⤢
REVENUE GROWTH YOY
13.08%
-28.2pp1.97%52.94%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
14.10%
+9.5pp-15.88%47.91%
⤢
RETURN ON CAPITAL
—
⤢
RETURN ON EQUITY (TTM)
38.14%
+59.8pp-31.71%38.14%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN63.44%
OPERATING MARGIN24.33%
NET MARGIN19.04%
FCF MARGIN14.10%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$0.2B
+2574%⤢
STOCK-BASED COMP
$0.0B
+34%⤢
CAPITAL EXPENDITURE
$0.1B
+426%⤢
SHARES OUTSTANDING
0.39B
+7%⤢
DIVIDEND / SHARE
—
BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
$1.1B
+1031%⤢
TOTAL DEBT
—
⤢
DEBT / EBITDA (TTM)
—
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 104.12%INSIDERS 0.27%OTHER / RETAIL 0.00%1,436 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| Blackrock Inc. | 10.33% | 39.0M | $3.30B | -2.2% |
| Vanguard Capital Management LLC | 6.63% | 25.0M | $2.12B | NEW |
| Vanguard Portfolio Management LLC | 5.09% | 19.2M | $1.63B | NEW |
| State Street Corporation | 4.75% | 17.9M | $1.52B | -0.9% |
| BAILLIE GIFFORD & CO | 3.92% | 14.8M | $1.25B | -5.1% |
| Invesco Ltd. | 3.62% | 13.7M | $1.16B | -2.9% |
| Alliancebernstein L.P. | 3.42% | 12.9M | $1.10B | +49.9% |
| Geode Capital Management, LLC | 3.27% | 12.3M | $1.05B | +12.2% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 2.58% | 9.7M | $826.0M | +21.8% |
| Wellington Management Group, LLP | 2.47% | 9.3M | $790.4M | +203.4% |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.